Odaily that YZi Labs is reviewing CEA Industries' response to its written consent solicitation process. These actions include employing a poison pill plan and amending the company's bylaws, aimed at thwarting and delaying shareholder rights. YZi Labs believes the board's actions are intended to consolidate its own power and have already postponed its 2025 annual meeting until after its anniversary on December 17th. Furthermore, YZi Labs refutes CEA Industries' claim that it has never considered alternative token strategies, pointing out that CEO David Namdar explicitly stated at an industry conference in November 2025 that he was considering a shift to assets such as Solana. YZi Labs urges the board to refrain from further actions and to ensure a fair nomination and election process for directors.
YZi Labs: Condemns CEA Industries' board for adopting a poison pill plan and stripping shareholders of their rights.
This article is machine translated
Show original
Source
Disclaimer: The content above is only the author's opinion which does not represent any position of Followin, and is not intended as, and shall not be understood or construed as, investment advice from Followin.
Like
Add to Favorites
Comments
Share
